Importantly, evidence supports that EZH2 can be recruited into the promoter of LATS2 to augment H3K27me3 methylation, thus restraining LATS2 expression in fulminant hepatic failure.12 The gene discussed is EZH2; the disease is Fulminant hepatic failure.